Internal Medicine · Houston, TX
NPI
1982729422
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
383 services
Medicare patients, 2024
166
Average age 72
Drug cost, 2024
$1.4M
216 prescriptions
Company payments, 2025
$49K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hussein A Tawbi was code 99215 (office e&m - established), 177 times for 100 patients. In total Hussein A Tawbi billed 383 services in 17 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 177 | 100 | $110.43 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 87 | 26 | $93.60 | $8,143 |
| 99215 Office E&M - Established | Office | 24 | 23 | $142.47 | $3,419 |
| 99205 Office E&M - New | Facility | 23 | 23 | $142.72 | $3,283 |
| 99441 Telephone Services | Office | 13 | 12 | $44.77 | $582 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $137.67 | $1,652 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $90.89 | $1,000 |
By year: 2022 $40K for 374 services; 2023 $47K for 444 services; 2024 $41K for 383 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hussein A Tawbi prescribed most often to Medicare patients was Braftovi (Encorafenib), with 43 prescriptions and refills. In total Hussein A Tawbi wrote 216 Medicare prescriptions that cost $1.4M.
Brand drugs: 115 claims; generic drugs: - claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hussein A Tawbi $49K ($47K in general payments such as food, travel and fees and $2,204 for research) from 5 companies. The largest payer was Merck Sharp & Dohme LLC with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.